Glenmark Pharmaceuticals standalone net profit rises 96.81% in the September 2024 quarter

Sales rise 19.56% to Rs 2594.89 crore

Net profit of Glenmark Pharmaceuticals rose 96.81% to Rs 595.06 crore in the quarter ended September 2024 as against Rs 302.35 crore during the previous quarter ended September 2023. Sales rose 19.56% to Rs 2594.89 crore in the quarter ended September 2024 as against Rs 2170.40 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales2594.892170.40 20 OPM %30.0120.43 -PBDT849.91458.89 85 PBT795.06409.04 94 NP595.06302.35 97

Powered by Capital Market - Live News